HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
収録刊行物
-
- Annals of Oncology
-
Annals of Oncology 30 (3), 447-455, 2019-03
Elsevier BV